Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bhumyamalaki (Phyllanthus amarus) is an Ayurvedic herb containing phyllanthin and hypophyllanthin as key bioactive compounds. These lignans provide hepatoprotective effects by modulating liver enzymes and reducing oxidative stress in hepatocytes.
Origin & History
Bhumyamalaki (Phyllanthus amarus) is a small annual herb native to tropical regions including India, widely used in global traditional medicine. The whole plant—leaves, stems, roots, and fruits—is harvested fresh or dried, with standard solvent extraction methods (methanol, hexane) used for phytochemical analysis.
Research Narrative (Provisional)
The research dossier reveals a significant gap in human clinical evidence, with no key human clinical trials, RCTs, or meta-analyses documented for Phyllanthus amarus. Current evidence is primarily preclinical, focusing on hepatoprotective and antioxidant research in laboratory settings.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Bhumyamalaki (Phyllanthus amarus) is a medicinal herb used in small therapeutic doses rather than as a food source, so macronutrient contribution is negligible in typical use. Key bioactive compounds include: Lignans - phyllanthin (0.5–1.2% dry weight) and hypophyllanthin (0.3–0.8% dry weight), identified as primary hepatoprotective constituents; Ellagitannins - geraniin, corilagin, and ellagic acid (total hydrolysable tannins approximately 2–8% dry weight), contributing strongly to antioxidant activity; Flavonoids - quercetin, rutin, and astragalin (total flavonoids approximately 1.5–3.5% dry weight expressed as quercetin equivalents); Alkaloids - phyllantidine and phyllantine in trace amounts (<0.1% dry weight); Phenolic acids - gallic acid and caffeic acid derivatives contributing to total phenolic content of approximately 15–35 mg GAE/g dry extract. Mineral content includes modest levels of potassium, calcium, and iron, though precise concentrations vary by growing region and are not standardized in literature. Vitamin C (ascorbic acid) has been detected in fresh plant material at approximately 20–40 mg/100g fresh weight. Dietary fiber is present in whole herb preparations but not quantified for therapeutic doses. Bioavailability note: Phyllanthin and hypophyllanthin show moderate oral bioavailability with first-pass metabolism; tannin-bound phenolics have reduced bioavailability unless hydrolyzed in the gut; standardized extracts normalized to phyllanthin content are preferred for consistent therapeutic effect.
Reported Mechanism (Provisional)
Phyllanthin and hypophyllanthin in Bhumyamalaki inhibit hepatic cytochrome P450 enzymes and reduce lipid peroxidation in liver cells. The herb's flavonoids like quercetin and gallic acid scavenge free radicals through electron donation pathways. These compounds also modulate hepatic stellate cell activation, reducing collagen synthesis and fibrosis progression.
Clinical Narrative (Provisional)
Limited human studies exist for Bhumyamalaki, with most evidence from animal models and in vitro research. Preclinical studies show 200-400mg/kg doses reduced liver enzyme levels (ALT, AST) by 40-60% in hepatotoxicity models. One small human pilot study (n=30) suggested improved liver function markers, but larger randomized controlled trials are needed. Traditional use data spans centuries but lacks modern clinical validation.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.